Maynard, MA -- Ischemix, Inc., a clinical-stage pharmaceutical company that has developed novel compounds for cytoprotection in the kidney, heart and other organ systems, announced today that David A. DeWahl, Jr., President and Chief Executive Officer, will present at the Biotech Showcase™ 2016 Conference to be held January 11 through January 13, 2016 in San Francisco, California.
Details of Ischemix' participation are as follows:
|Event:||Biotech Showcase™ 2016 Conference|
|Date:||January 13, 2016|
|Time:||9:00 a.m. Pacific Time|
|Location:||Parc 55 Wyndham Hotel San Francisco, Track E, Davidson Room|
Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and potential strategic partners.